Higinio Dopeso Selected Research

Neoplasm Metastasis (Metastasis)

11/2022	Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression.
1/2018	PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα.
1/2017	Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.
11/2014	RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Higinio Dopeso Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 09/2009
10	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 04/2010
6	Colonic Neoplasms (Colon Cancer) 01/2017 - 10/2009
4	Neoplasm Metastasis (Metastasis) 11/2022 - 11/2014
3	Microsatellite Instability 04/2013 - 10/2009
2	Carcinogenesis 01/2022 - 09/2009
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 04/2013
2	Hypoxia (Hypoxemia) 01/2018 - 11/2014
1	Disease Progression 11/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Residual Neoplasm 01/2022
1	Plasmacytoma 01/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Lymphatic Metastasis 01/2017
1	Chromosomal Instability (Chromosome Stability) 04/2012

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2009
3	Messenger RNA (mRNA)IBA 01/2021 - 10/2009
2	Transcription Factors (Transcription Factor)IBA 11/2022 - 01/2022
2	Calcibiotic Root Canal SealerIBA 11/2022 - 04/2012
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017 - 09/2009
2	AgarIBA 01/2017 - 01/2012
2	Myosin Type I (Myosin IA)IBA 04/2013 - 01/2012
1	ChromatinIBA 11/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Verteporfin (Visudyne)FDA Link 01/2022
1	Biological ProductsIBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Competitive Endogenous RNAIBA 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	LigandsIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	EphA1 Receptor (Eph Receptor)IBA 01/2017
1	acifluorfen (Blazer)IBA 08/2015
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 08/2015
1	Small Interfering RNA (siRNA)IBA 08/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2015
1	Protoporphyrinogen Oxidase (Protox)IBA 08/2015
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 11/2014
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 11/2014
1	CateninsIBA 11/2014
1	Monomeric GTP-Binding ProteinsIBA 11/2014
1	Decitabine FDA Link 04/2013
1	Cycloheximide (Cicloheximide)IBA 04/2013
1	villinIBA 04/2012
1	CarcinogensIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 04/2010
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2010
1	ErbB Receptors (EGF Receptor)IBA 10/2009
1	Adenosine (Adenocard)FDA LinkGeneric 10/2009

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2010
1	Hyperthermic Intraperitoneal Chemotherapy 01/2022